Relationship between Chemotherapy-Induced Diarrhea and Intestinal Microbiome Composition.
暂无分享,去创建一个
K. Higuchi | T. Takeuchi | K. Ota | Shiro Nakamura | T. Miyazaki | T. Terazawa | Yuki Hirata | K. Kakimoto | Haruka Yokota | R. Koshiba | N. Sakiyama | Hikaru Shimizu | Keijiro Numa | Y. Kawasaki | Hiroki Nishikawa | Hiroshi Ohno | M. Goto | Yutaka Makizaki | Kei Nakazawa | Yasuyoshi Tanaka | Koji Nishida | Shunji Nakajima | Naohiko Kinoshita | Yoshihiro Tatsumi | Yoshiki Tanaka
[1] H. Ohno,et al. Improvement of loperamide-induced slow transit constipation by Bifidobacterium bifidum G9-1 is mediated by the correction of butyrate production and neurotransmitter profile due to improvement in dysbiosis , 2021, PloS one.
[2] I. Yasuda,et al. Small intestinal mucosal injury and its risk factors in patients with gastrointestinal cancer who developed complicated fluoropyrimidine-induced diarrhea , 2020, BMC Gastroenterology.
[3] A. Kondo,et al. Construction of a Model Culture System of Human Colonic Microbiota to Detect Decreased Lachnospiraceae Abundance and Butyrogenesis in the Feces of Ulcerative Colitis Patients. , 2019, Biotechnology journal.
[4] K. Higuchi,et al. Fluoropyrimidine-induced intestinal mucosal injury is associated with the severity of chemotherapy-related diarrhea , 2019, Scandinavian journal of gastroenterology.
[5] Yoshiki Tanaka,et al. Alleviation of low-fiber diet-induced constipation by probiotic Bifidobacterium bifidum G9-1 is based on correction of gut microbiota dysbiosis , 2018, Bioscience of microbiota, food and health.
[6] N. Hamouda,et al. Probiotic Bifidobacterium bifidum G9‐1 attenuates 5‐fluorouracil‐induced intestinal mucositis in mice via suppression of dysbiosis‐related secondary inflammatory responses , 2017, Clinical and experimental pharmacology & physiology.
[7] K. Higuchi,et al. Apoptosis, Dysbiosis and Expression of Inflammatory Cytokines are Sequential Events in the Development of 5‐Fluorouracil‐Induced Intestinal Mucositis in Mice , 2017, Basic & clinical pharmacology & toxicology.
[8] C. Yeung,et al. Amelioration of Chemotherapy-Induced Intestinal Mucositis by Orally Administered Probiotics in a Mouse Model , 2015, PloS one.
[9] Gabriel A. Al-Ghalith,et al. Chemotherapy‐driven dysbiosis in the intestinal microbiome , 2015, Alimentary pharmacology & therapeutics.
[10] E. Souza,et al. Regulatory role of Lactobacillus acidophilus on inflammation and gastric dysmotility in intestinal mucositis induced by 5-fluorouracil in mice , 2015, Cancer Chemotherapy and Pharmacology.
[11] P. Gajer,et al. An improved dual-indexing approach for multiplexed 16S rRNA gene sequencing on the Illumina MiSeq platform , 2014, Microbiome.
[12] M. Tomita,et al. Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells , 2013, Nature.
[13] K. Takeuchi,et al. 5‐HT3 receptor antagonists ameliorate 5‐fluorouracil‐induced intestinal mucositis by suppression of apoptosis in murine intestinal crypt cells , 2013, British journal of pharmacology.
[14] C. Yabe-Nishimura,et al. Potential role of the NADPH oxidase NOX1 in the pathogenesis of 5-fluorouracil-induced intestinal mucositis in mice. , 2012, American journal of physiology. Gastrointestinal and liver physiology.
[15] W. Tissing,et al. The Role of Intestinal Microbiota in the Development and Severity of Chemotherapy-Induced Mucositis , 2010, PLoS pathogens.
[16] William A. Walters,et al. QIIME allows analysis of high-throughput community sequencing data , 2010, Nature Methods.
[17] W. Tissing,et al. Chemotherapy treatment in pediatric patients with acute myeloid leukemia receiving antimicrobial prophylaxis leads to a relative increase of colonization with potentially pathogenic bacteria in the gut. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[18] G. Howarth,et al. Effects of Streptococcus thermophilus TH-4 on intestinal mucositis induced by the chemotherapeutic agent, 5-Fluorouracil (5-FU) , 2009, Cancer biology & therapy.
[19] H. Joensuu,et al. Lactobacillus supplementation for diarrhoea related to chemotherapy of colorectal cancer: a randomised study , 2007, British Journal of Cancer.
[20] S. Sonis,et al. The role of pro-inflammatory cytokines in cancer treatment-induced alimentary tract mucositis: pathobiology, animal models and cytotoxic drugs. , 2007, Cancer treatment reviews.
[21] Jeffrey A Jones,et al. Epidemiology of treatment-associated mucosal injury after treatment with newer regimens for lymphoma, breast, lung, or colorectal cancer , 2006, Supportive Care in Cancer.
[22] B. D. de Pauw,et al. Mucosal barrier injury: biology, pathology, clinical counterparts and consequences of intensive treatment for haematological malignancy: an overview , 2000, Bone Marrow Transplantation.
[23] C. Sarraf,et al. The nature of cytotoxic drug-induced cell death in murine intestinal crypts. , 1992, British Journal of Cancer.